Cases & Deals

ADOCIA completes IPO on NYSE Euronext in Paris

Clients ADOCIA

Jones day advised ADOCIA, a biotechnology company specialized in protein delivery, in connection with its €27.4 million (US$36.6 million) initial public offering of Common Stock on the regulated market of NYSE Euronext in Paris. Dexia Securities France acted as lead manager and bookrunner.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.